These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 1009519

  • 1. Adrenalectomy and oophorectomy plus limited-term chemotherapy in the treatment of breast cancer.
    Hoge AF, Bottomley RH, Shaw MT, Asal NR.
    Cancer Treat Rep; 1976 Jul; 60(7):857-65. PubMed ID: 1009519
    [Abstract] [Full Text] [Related]

  • 2. [Present status of endocrine therapy of breast cancer: a surgeon's view].
    Nomura Y.
    Gan To Kagaku Ryoho; 1984 May; 11(5):981-8. PubMed ID: 6426405
    [Abstract] [Full Text] [Related]

  • 3. Adrenal ablation.
    Janelli DE, Monteleone F, Mishrick A, Kashiwabara H.
    Int Surg; 1979 May; 64(4):27-31. PubMed ID: 94043
    [Abstract] [Full Text] [Related]

  • 4. Antiestrogen-induced remissions in stage IV breast cancer.
    Manni A, Trujillo J, Marshall JS, Pearson OH.
    Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
    [Abstract] [Full Text] [Related]

  • 5. Salvage treatment of patients relapsing after breast cancer adjuvant chemotherapy.
    Wendt AG, Jones SE, Salmon SE.
    Cancer Treat Rep; 1980 Oct; 64(2-3):269-73. PubMed ID: 6893293
    [Abstract] [Full Text] [Related]

  • 6. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
    Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J.
    Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):1062-73. PubMed ID: 15234040
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
    Kuerer HM, Newman LA, Buzdar AU, Dhingra K, Hunt KK, Buchholz TA, Binkley SM, Strom EA, Ames FC, Ross MI, Feig BW, McNeese MD, Hortobagyi GN, Singletary SE.
    Cancer J Sci Am; 1998 Jul 15; 4(4):230-6. PubMed ID: 9689981
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. First, second and third line chemotherapy programs in metastatic breast carcinoma.
    Rizel S, Sulkes A, Gez E, Brufman G, Biran S.
    Isr J Med Sci; 1981 Jul 15; 17(9-10):946-53. PubMed ID: 6171542
    [Abstract] [Full Text] [Related]

  • 17. Treatment of advanced and relapsing breast cancer with a combination of paclitaxel and mitoxantrone. South-Central Hellenic Oncology Group.
    Panagos GE.
    Semin Oncol; 1997 Feb 15; 24(1 Suppl 3):S17-21. PubMed ID: 9071335
    [Abstract] [Full Text] [Related]

  • 18. [Bilateral adrenalectomy for advanced breastcarcinoma (author's transl)].
    Vannineuse A.
    Acta Chir Belg; 1981 Feb 15; 80(1):1-9. PubMed ID: 7257689
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.